Affymax (AFFY) Shows Signs of Life
Tweet
Share
E-mailGet Alerts AFFY Hot Sheet
Join SI Premium – FREE
Affymax (Nasdaq: AFFY) showed signs of life on Tuesday, gaining 37%. Investors in the stock were punished earlier this year after the company recalled OMONTYS injections due to reports of serious hypersensitivity reactions. Since then share are lower by about 95%.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic hires Google chip veteran as it pushed into hardware - Bloomberg
- Nscale targets up to $3B in US IPO as soon as September - Bloomberg
- SEC accuses ex-BofA senior banker Satsky of insider trading - Bloomberg
Create E-mail Alert Related Categories
Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
